MeiraGTx Holdings plc (MGTX) earnings date
Mar 18, 2027, before open estimated
Estimated from the company's SEC filing cadence. The company has not confirmed it. Companies usually announce two to four weeks ahead.
- Fiscal period
- Q4 FY2026
- Confidence
- 52% chance of landing within a day
- Source
- Filing history on EDGAR
- Last checked
- 2026-11-19
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
How this company behaves
| Announces its report date | Not enough announcements on file yet to say |
| Reports after the quarter ends | 44 days, typically, give or take 16 (last 8 releases) |
Last 8 releases
| Period | Released | Timing | Days after period end | Filing |
|---|---|---|---|---|
| Q3 FY2026 | Thu, Nov 12, 2026 | before open | 43 | 8-K |
| Q2 FY2026 | Thu, Aug 13, 2026 | before open | 44 | 8-K |
| Q1 FY2026 | Thu, May 14, 2026 | before open | 44 | 8-K |
| Q4 FY2025 | Thu, Mar 26, 2026 | before open | 85 | 8-K |
| Q3 FY2025 | Thu, Nov 13, 2025 | before open | 44 | 8-K |
| Q2 FY2025 | Thu, Aug 14, 2025 | before open | 45 | 8-K |
| Q1 FY2025 | Tue, May 13, 2025 | before open | 43 | 8-K |
| Q4 FY2024 | Thu, Mar 13, 2025 | before open | 72 | 8-K |
What they guided beta
| Q3 FY2026 | "Submission of Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for botaretigene sparoparvovec (bota-vec) for the treatment of X-linked retinitis pigmentosa (XLRP) expected in December 2026" exhibit |
| Q3 FY2026 | "Submission of full Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for bota-vec expected in the first quarter of 2027" exhibit |
| Q3 FY2026 | "The Company anticipates that this will be followed by the submission of the full BLA to the FDA in the first quarter of 2027." exhibit |
| Q3 FY2026 | "In order to expedite the use of the Company’s proprietary, optimized small molecule for both of these riboswitch targets, a single ascending dose/multiple ascending dose (SAD/MAD) study of the Company’s lead small molecule is expected to initiate in December 2026." exhibit |
| Q3 FY2026 | "The increase of $1.0 million was due to higher cash balances in interest bearing accounts during 2026 offset by lower interest rates. Financial related costs, net reflected a gain of $1.6 million for the three months ended September 30, 2026 compared to an expense of $3.1 million for the three months ended September 30, 2025." exhibit |
| Q2 FY2026 | "EX-99.1 2 mgtx-20260813xex99d1.htm EX-99.1 Exhibit 99.1 MeiraGTx Reports Second Quarter 2026 Financial and Operational Results - Received FDA Breakthrough Therapy Designation for AAV2-hAQP1 and reported positive three-year data from Phase 1 AQUAx clinical trial evaluating AAV2-hAQP1 for the treatment of moderate to severe grade 2/3 radiation-induced xerostomia - Completed the acquisition of all interests and rights to botaretigene sparoparvovec (bota-vec) for the treatment of X-linked retinitis pigmentosa (XLRP) from Johnson & Johnson* (J&J) for $25 million - Strengthened balance sheet with $" exhibit |
| Q2 FY2026 | "The increase of $0.3 million was due to higher cash balances in interest bearing accounts during 2026 offset by lower interest rates." exhibit |
Get this as JSON
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/next/MGTX
# how far back the record goes for this company
curl -H "X-API-Key: vt_live_..." https://api.veritasdata.dev/v1/coverage/MGTX
Put this date on your page
A badge that stays current. It links back to this page and needs no key. Embed it unmodified, with its link to this page intact: the badge is too small to carry the notice below, so the page it links to does.
Read by software from public filings and company announcements. Can be wrong. Verify with the company or the SEC. Not investment advice.
HTML
<a href="https://veritasdata.dev/company/MGTX/"><img src="https://veritasdata.dev/embed/MGTX.svg" alt="MGTX earnings date" width="240" height="56"></a>
Markdown
[](https://veritasdata.dev/company/MGTX/)
Script
<script async src="https://veritasdata.dev/embed/MGTX.js"></script>
Get a free key: 100 calls, every company
Sign in with GitHub or Google. The key works on every endpoint and in the MCP server.
curl -H "X-API-Key: vt_live_..." "https://api.veritasdata.dev/v1/next/MGTX"
Dates come only from SEC EDGAR and company announcements. Nothing here is investment advice.